Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
15 Sep 2026

DexCom, Inc. reported A director or senior management change or compensation event

DexCom, Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

11 Sep 2026

DexCom, Inc. reported A director or senior management change or compensation event

DexCom, Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

31 Jul 2026

DexCom, Inc. filed Form 10-Q

DexCom, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

31 Jul 2026

DexCom, Inc. reported Operating or financial results

DexCom, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

29 May 2026

DexCom, Inc. reported Shareholder voting results

DexCom, Inc. filed an 8-K covering shareholder voting results.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$1.11B
Total assets (USD)$6.46B
Total liabilities (USD)$3.83B
Shareholders' equity (USD)$2.62B
Long-term debt (USD)$2.90M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
QuarterRevenue (USD)Operating incomeNet incomeDiluted EPS (USD)Filed
Q2 2026$1.31B$318.30M$249.10M$0.6410-Q · 30 Jul 2026
Q1 2026$1.19B$255.30M$199.50M$0.5110-Q · 30 Apr 2026
Q4 2025$1.26B$323.00M$267.30MUnavailable10-K · 12 Feb 2026
Q3 2025$1.21B$242.50M$283.80M$0.7010-Q · 30 Oct 2025
Q2 2025$1.16B$212.60M$179.80M$0.4510-Q · 30 Jul 2025
Q1 2025$1.04B$133.70M$105.40M$0.2710-Q · 1 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy
Target: $96.39
20.1% upside potential
📈
Strong Buy
Unavailable
👍
Buy
19
⏸️
Hold
1
📉
Sell
0
20 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 82.00–115.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
15
Oct 2026
Brown Michael Jon
EVP Chief Legal Compliance Off
Open-market sale
$85.48 per share
1,700 shares
SEC Form 4
28
Sep 2026
Stern Sadie
EVP Chief People & Culture Off
Open-market sale
$86.15 per share
2,565 shares
SEC Form 4
15
Sep 2026
AUGUSTINOS NICHOLAS
Director
Open-market sale
$84.04 per share
6,539 shares
SEC Form 4
15
Sep 2026
Brown Michael Jon
EVP Chief Legal Compliance Off
Open-market sale
$84.04 per share
1,700 shares
SEC Form 4
14
Sep 2026
AUGUSTINOS NICHOLAS
Director
Open-market sale
$84.02 per share
1,550 shares
SEC Form 4
10
Sep 2026
Sylvain Jereme M
EVP, Chief Financal Officer
Open-market sale
$83.27 per share
3,638 shares
SEC Form 4
10
Sep 2026
Boehnlein Glenn S
Director
Grant or award
Unavailable per share
5,841 shares
SEC Form 4
27
Aug 2026
Stern Sadie
EVP Chief People & Culture Off
Open-market sale
$88.37 per share
2,565 shares
SEC Form 4
22
Aug 2026
Leach Jacob Steven
Director, President, CEO, and Director
Tax withholding
$92.34 per share
1,451 shares
SEC Form 4

Top Shareholders

Vanguard Group Inc
49,074,378 shares
-0.772% change
12/31/2025
Blackrock, Inc.
38,244,137 shares
-1.848% change
6/30/2026
Vanguard Capital Management Llc
25,209,752 shares
0.755% change
6/30/2026
Vanguard Portfolio Management Llc
19,656,540 shares
2.272% change
6/30/2026
State Street Corp
18,380,806 shares
2.487% change
6/30/2026
Invesco Ltd.
15,288,133 shares
11.818% change
6/30/2026
Baillie Gifford & Co
14,801,590 shares
-5.115% change
6/30/2026
Geode Capital Management, Llc
12,426,515 shares
0.647% change
6/30/2026
Alliancebernstein L.P.
11,693,409 shares
-9.519% change
6/30/2026
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame
11,261,876 shares
15.552% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 1 day ago